Isosceles Pharmaceuticals
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1213 Culbreth Dr, Wilmington, North Caro...Website
www.isoscelespharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Isosceles Pharmaceuticals
Isosceles Pharmaceuticals is a specialty pharmaceutical company focused on developing parenteral products that address the unmet need for novel non-opioid, non-NSAID analgesics aimed at treating acute pain. Their mission is to leverage the body's endocannabinoid system to alleviate pain and inflammation, ultimately reducing patient suffering. The company offers rapid onset pain relief alternatives for physicians. Their target clients include healthcare professionals seeking effective pain management solutions.Explore more
Isosceles Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Isosceles Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Isosceles Pharmaceuticals recently announced quarterly report
Click to see if Isosceles Pharmaceuticals had a recent Job posting/layoffs
Check out if Isosceles Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Isosceles Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Isosceles Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Isosceles Pharmaceuticals has new funding data
Product Launch: Get notified when Isosceles Pharmaceuticals launches new products
Isosceles Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Isosceles Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Isosceles Pharmaceuticals
Compare insights from companies similar to Isosceles Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Isosceles Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Isosceles Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Isosceles Pharmaceuticals.
Isosceles Pharmaceuticals Tech Stack
A closer look at the technologies used by Isosceles Pharmaceuticals
Isosceles Pharmaceuticals News & Media
Isosceles Pharmaceuticals Announces Acceptance of IPI201 for Phase I First-in-Human Clinical Trial
Novel intravenous anti-inflammatory candidate advances to Phase I evaluation to assess safety, tolerability, and pharmacokinetics. WILMINGTON, NC, UNITED STATES, February 11, 2026 /EINPresswire.com/ -- Isosceles Pharmaceuticals today announced that its …Isosceles Pharmaceuticals Signs Non-Binding Letter of Intent With a Strategic Partner for Phase 1 Development of Its Proprietary Synthetic Cannabidiol Intravenous Product
WILMINGTON, N.C., Oct. 31, 2022 /PRNewswire/ -- Isosceles Pharmaceuticals, Inc., a preclinical stage pharmaceutical company ("Isosceles", or the "Company") engaged in the development of synthetic cannabidiol for the treatment of pain has announced the execution of a non-binding letter of...Isosceles Pharmaceuticals Names Chief Medical Officer, Strategic Advisor - NewsBreak
Wilmington-based Isosceles Pharmaceuticals recently welcomed two new team members – Herbert Neuman and Thomas L. Harrison, according to a news release. Isosceles, an early-stage venture launched two years ago, set out to formulate and commercialize products that effectively and safely treat post-operative acute pain, the release stated. "Using synthetic cannabidiol...Isosceles Pharmaceuticals appoints Herbert Neuman, MD, MBA Chief...
Growing Isosceles Pharmaceuticals team pushes to develop novel, non-opioid products to treat acute pain (PRWeb September 14, 2021) Read the full story at https://www.prweb.com/releases/isosceles_pharmaceuticals_appoints_herbert_neuman_md_mba_chief_medical_officer_and_adds_thomas_harrison_lh_d_as_a_strategic_advisor/prweb18189713.htm
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Isosceles Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Isosceles Pharmaceuticals is a specialty pharmaceutical company focused on developing parenteral products that address the unmet need for novel non-opioid, non-NSAID analgesics aimed at treating acute pain. Their mission is to leverage the body's endocannabinoid system to alleviate pain and inflammation, ultimately reducing patient suffering. The c... Read More
